<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>30(1)</volume><submitter>Liu E</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>This study aimed to establish the G-Risk scoring system, a prognostic model based on inflammatory and tumor biomarkers, to enhance survival predictions for gastric cancer patients without lymphovascular invasion (LVI) and guide more tailored treatment strategies.&lt;h4>Methods&lt;/h4>The key biomarkers associated with survival outcomes were identified using univariate and multivariate Cox regression analyses. These biomarkers were selected from a range of inflammatory and tumor markers to construct the G-Risk scoring system, which was specifically developed to improve prognostic accuracy in patients without LVI.&lt;h4>Results&lt;/h4>The G-Risk score effectively stratified patients into high-risk and low-risk groups, achieving an AUC of 0.660, demonstrating strong predictive performan</pubmed_abstract><journal>European journal of medical research</journal><pagination>308</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12008984</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Development of the G-Risk scoring system utilizing inflammatory and tumor biomarkers to improve prognostic accuracy in gastric cancer patients without lymphovascular invasion.</pubmed_title><pmcid>PMC12008984</pmcid><pubmed_authors>Shi L</pubmed_authors><pubmed_authors>Lv L</pubmed_authors><pubmed_authors>Li C</pubmed_authors><pubmed_authors>Xu B</pubmed_authors><pubmed_authors>Guo H</pubmed_authors><pubmed_authors>Liu E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Development of the G-Risk scoring system utilizing inflammatory and tumor biomarkers to improve prognostic accuracy in gastric cancer patients without lymphovascular invasion.</name><description>&lt;h4>Objective&lt;/h4>This study aimed to establish the G-Risk scoring system, a prognostic model based on inflammatory and tumor biomarkers, to enhance survival predictions for gastric cancer patients without lymphovascular invasion (LVI) and guide more tailored treatment strategies.&lt;h4>Methods&lt;/h4>The key biomarkers associated with survival outcomes were identified using univariate and multivariate Cox regression analyses. These biomarkers were selected from a range of inflammatory and tumor markers to construct the G-Risk scoring system, which was specifically developed to improve prognostic accuracy in patients without LVI.&lt;h4>Results&lt;/h4>The G-Risk score effectively stratified patients into high-risk and low-risk groups, achieving an AUC of 0.660, demonstrating strong predictive performan</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Apr</publication><modification>2025-07-03T03:04:56.902Z</modification><creation>2025-07-03T03:04:56.902Z</creation></dates><accession>S-EPMC12008984</accession><cross_references><pubmed>40251687</pubmed><doi>10.1186/s40001-025-02540-4</doi></cross_references></HashMap>